Cytori Therapeutics, Inc. (CYTX) Tops Q2 EPS by 1c
Tweet Send to a FriendGet Alerts CYTX Hot Sheet
Price: $2.57 +2.39%
Revenue Growth %: +251.0%
Financial Fact:
Total Development Revenues: 2.37M
Today's EPS Names:
ANF, DXLG, FL, More
Revenue Growth %: +251.0%
Financial Fact:
Total Development Revenues: 2.37M
Today's EPS Names:
ANF, DXLG, FL, More
Trade CYTX Now!
Cytori Therapeutics, Inc. (NASDAQ: CYTX) reported Q2 EPS of ($0.13), $0.01 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $4.4 million versus the consensus estimate of $2.46 million.
For earnings history and earnings-related data on Cytori Therapeutics, Inc. (CYTX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Cytori Therapeutics, Inc. (CYTX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- salesforce.com, Inc. (CRM) Reports In-Line Q1 EPS; Issues In-Line Q2, FY14 Outlook
- UPDATE: 8x8 Inc. (EGHT) Misses Q4 EPS by 1c
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
